# Implantation or Injectable New Animal Drugs; Flunixin Meglumine Solution
> **Food and Drug Administration** · Final rule. · Published 1995-10-27 · 60 FR 54941
## Document
- **Document number:** 95-26633
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 60 FR 54941
- **CFR reference:** 21 CFR 522
- **Publication date:** 1995-10-27
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The ANADA provides for intravenous or intramuscular use of flunixin meglumine injection for alleviation of inflammation and pain associated with musculoskeletal disorders and visceral pain associated with colic in horses.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1995/10/27/95-26633/implantation-or-injectable-new-animal-drugs-flunixin-meglumine-solution)
---
*AI Analytics · CC0 1.0*